Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to $2804.0.

  • cbdMD's Capital Expenditures fell 7196.0% to $2804.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $184172.0, marking a year-over-year decrease of 307.5%. This contributed to the annual value of $184172.0 for FY2025, which is 307.5% down from last year.
  • As of Q3 2025, cbdMD's Capital Expenditures stood at $2804.0, which was down 7196.0% from $1475.0 recorded in Q2 2025.
  • cbdMD's Capital Expenditures' 5-year high stood at $231030.0 during Q4 2021, with a 5-year trough of -$102390.0 in Q1 2023.
  • Its 5-year average for Capital Expenditures is $89396.4, with a median of $95407.5 in 2022.
  • Its Capital Expenditures has fluctuated over the past 5 years, first skyrocketed by 64392.76% in 2022, then tumbled by 17171.93% in 2023.
  • Over the past 5 years, cbdMD's Capital Expenditures (Quarter) stood at $231030.0 in 2021, then decreased by 23.23% to $177370.0 in 2022, then rose by 4.1% to $184635.0 in 2023, then decreased by 10.97% to $164387.0 in 2024, then plummeted by 98.29% to $2804.0 in 2025.
  • Its last three reported values are $2804.0 in Q3 2025, $1475.0 for Q2 2025, and $15506.0 during Q1 2025.